Haemonetics Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4050241003
USD
83.81
1.9 (2.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
321.39
330.60
348.54
345.51
336.17
343.29
336.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
321.39
330.60
348.54
345.51
336.17
343.29
336.25
Raw Material Cost
140.93
148.68
164.20
166.57
169.35
171.69
158.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.07
0.00
11.09
8.51
5.71
9.96
3.56
Selling and Distribution Expenses
109.75
114.50
105.97
105.92
107.98
106.44
111.15
Other Expenses
1.15
1.60
0.47
0.80
0.87
0.40
0.94
Total Expenditure (Excl Depreciation)
266.26
279.13
286.00
289.02
291.79
292.13
282.30
Operating Profit (PBDIT) excl Other Income
55.099999999999994
51.5
62.5
56.5
44.400000000000006
51.2
53.9
Other Income
0.00
3.10
0.00
1.62
-0.16
5.29
1.92
Operating Profit (PBDIT)
83.90
82.77
91.57
87.33
73.36
84.09
79.40
Interest
4.07
0.00
11.09
8.51
5.71
9.96
3.56
Exceptional Items
-5.90
16.18
-1.54
-4.90
8.20
-23.08
-8.28
Gross Profit (PBDT)
180.47
181.92
184.34
178.94
166.82
171.60
178.02
Depreciation
28.76
28.21
29.02
29.22
29.14
27.64
23.53
Profit Before Tax
45.17
70.74
49.92
44.70
46.71
23.41
44.03
Tax
11.14
12.76
12.42
10.87
8.34
3.05
12.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
34.03
57.98
37.49
33.83
38.37
20.37
31.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
34.03
57.98
37.49
33.83
38.37
20.37
31.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
34.03
57.98
37.49
33.83
38.37
20.37
31.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
882.30
820.84
906.86
878.85
905.37
959.96
943.32
Earnings per share (EPS)
0.7
1.17
0.74
0.66
0.74
0.4
0.61
Diluted Earnings per share
0.7
1.17
0.74
0.66
0.74
0.4
0.61
Operating Profit Margin (Excl OI)
17.16%
15.57%
17.94%
16.35%
13.2%
14.9%
16.04%
Gross Profit Margin
23.0%
29.93%
22.65%
21.39%
22.56%
14.87%
20.09%
PAT Margin
10.59%
17.54%
10.76%
9.79%
11.41%
5.93%
9.29%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -2.78% vs -5.14% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -41.38% vs 54.67% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 5.27% vs -12.99% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Haemonetics Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
321.39
682.10
-360.71
-52.88%
Other Operating Income
0.00
0.00
0.00
Total Operating income
321.39
682.10
-360.71
-52.88%
Raw Material Cost
140.93
311.90
-170.97
-54.82%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.07
8.00
-3.93
-49.12%
Selling and Distribution Expenses
109.75
291.10
-181.35
-62.30%
Other Expenses
1.15
2.03
-0.88
-43.35%
Total Expenditure (Excl Depreciation)
266.26
631.30
-365.04
-57.82%
Operating Profit (PBDIT) excl Other Income
55.14
50.80
4.34
8.54%
Other Income
0.00
2.40
-2.40
-100.00%
Operating Profit (PBDIT)
83.90
83.00
0.90
1.08%
Interest
4.07
8.00
-3.93
-49.12%
Exceptional Items
-5.90
-4.50
-1.40
-31.11%
Gross Profit (PBDT)
180.47
370.20
-189.73
-51.25%
Depreciation
28.76
29.80
-1.04
-3.49%
Profit Before Tax
45.17
40.70
4.47
10.98%
Tax
11.14
14.30
-3.16
-22.10%
Provisions and contingencies
0
0
0.00
Profit After Tax
34.03
26.40
7.63
28.90%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
34.03
26.40
7.63
28.90%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
34.03
26.40
7.63
28.90%
Equity Capital
0
0
0.00
Face Value
0.01
0.01
0.00
Reserves
882.30
3,139.00
-2,256.70
-71.89%
Earnings per share (EPS)
0.70
0.16
0.54
337.50%
Diluted Earnings per share
0.70
0.16
0.54
337.50%
Operating Profit Margin (Excl OI)
17.16%
7.45%
0.00
9.71%
Gross Profit Margin
23.00%
10.34%
0.00
12.66%
PAT Margin
10.59%
3.87%
0.00
6.72%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 32.14 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -2.78% vs -5.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -4.40% vs 8.00% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.40 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -41.38% vs 54.67% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -11.46% vs -6.34% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.39 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 5.27% vs -12.99% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.15% vs -4.17% in Jun 2024

Quarterly - Interest
Interest 0.41 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -100.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -28.07% vs 850.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.16%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024